Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats

Psychopharmacology

Volumn 153, Issue 1, 2000, Pages 93-102

  Holter S M ^a   Henniger, M S H ^a   Lipkowski, A W ^a   Spanagel, R ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Alcohol deprivation effect; Enadoline (CI 977); Nor binaltorphimine (nor BNI); Relapse; Voluntary ethanol self administration; opioid receptor

Indexed keywords

ALCOHOL; DYNORPHIN; ENADOLINE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE;

ALCOHOL ABSTINENCE; ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; MOTIVATION; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; REINFORCEMENT; RELAPSE; SEDATION;

ALCOHOL DRINKING; ANIMALS; BENZOFURANS; CONDITIONING, OPERANT; DRINKING; EATING; MALE; NALTREXONE; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; RECURRENCE; SELF ADMINISTRATION;

EID: 0034494199     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130000601     Document Type: Article

References (55)

1. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats
2. Aversive properties of the kappa opioid agonist U50,488 in the week-old rat pup
3. Effects of voluntary short-term abstinence from alcohol on subsequent drinking patterns of college students
4. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys
5. Reinforcement theory and the dynamics of alcoholism
6. Endorphins and food intake: Kappa opioid receptor agonists and hyperphagia
7. Pharmacologic activity of CI-977, a selective kappa opioid agonist, in rhesus monkeys
8. Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects
9. Nor-binaltorphimine: A potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo
10. Opioid involvement in alcohol drinking
11. Blockade of morphine through the activation of kappa-opioid receptors in mice
12. Characterization of the effects of acute ethanol administration on the release of β-endorphin peptides by the rat hypothalamus
13. Implication of the endogenous opioid system in excessive ethanol consumption
14. Effects of acute and chronic ketocyclazocine and its modulation by oxytocin and vasopressin on food intake in rats
15. Kappa agonists and vasopressin secretion
16. Endogenous opioid systems and alcohol addiction
17. Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats
18. Increased motivation to work for alcohol during the alcohol deprivation effect
19. Evidence for alcohol anti-craving properties of memantine
20. Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation
21. Long-term ethanol self-administration with repeated ethanol deprivation episodes changes ethanol drinking pattern and increases anxiety-related behaviour during ethanol deprivation in rats
22. Novel uncompetitive N-methyl-D-aspartate (NMDA)-receptor antagonist MRZ 2/579 suppresses ethanol intake in long-term ethanol-experienced rats and generalizes to ethanol cue in drug discrimination procedure
23. Withdrawal symptoms in a long-term model of voluntary alcohol drinking in Wistar rats
24. Extremely long-lasting antagonistic actions of nor-binaltorphimine (nor-BNI) in the mouse tail flick test
25. CI-977, a novel and selective agonist for the kappa opioid receptor
26. Content of dynorphins and κ-opioid receptors in distinct brain regions of C57BL/6 and DBA/2 mice
27. Human psychopharmacology of ketocyclazocine as compared with cyclazocine, morphine and placebo
28. Kappa agonist-induced diuresis: Evidence for stereoselectivity, strain differences, independence of hydration variables and a result of decreased plasma vasopressin levels
29. Free-feeding and free-drinking patterns of male rats following treatment with opiate kappa agonists
30. Dynorphin, an endogenous stimulator of feeding
31. Effects of microinjections of mu and kappa receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus maze test
32. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning
33. Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference
34. Psychotomimesis mediated by κ opiate receptors
35. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists
36. Ethanol withdrawal enhances the prodynorphin system activity in the rat nucleus accumbens
37. The cardiovascular and central nervous system effects in the human of U-62066E. A selective opioid receptor agonist
38. Disruption of the κ-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ-agonist U-50,488H and attenuates morphine withdrawal
39. The alcohol-deprivation effect in monkeys
40. Increased preference for ethanol in rats following alcohol deprivation
41. Stress response dampening: Effects of gender and family history of alcoholism and anxiety disorders
42. 3H]ethylketocyclazocine binding to brain opioid receptor subtypes in alcohol-preferring AA and alcohol-avoiding ANA rats
43. Long-term alcohol self-administration with repeated alcohol deprivation phases: An animal model of alcoholism?
44. Pharmacological validation of a new animal model of alcoholism
45. The dopamine hypothesis of reward: Past and current status
46. The effects of opioid peptides on dopamine release in the nucleus accumbens: An in vivo microdialysis study
47. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway
48. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes
49. Acamprosate and alcohol. I. Effects on alcohol intake following alcohol deprivation in the rat
50. Anxiety sensitivity and self-reported reasons for drug use
51. Tension reduction and the effects of prolonged alcohol consumption
52. Oral ethanol-reinforced responding in rhesus monkeys - Effects of opioid antagonists selective for the mu-, kappa-, or delta-receptor
53. Differences in the kappa opioid receptor mRNA content in distinct brain regions of two inbred mice strains
54. A psychomotor stimulant theory of addiction
55. The kappa-opioid receptor: Evidence for the different subtypes